(Q43551236)

24 November 2017

title

Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis (English)

1 reference

24 November 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jakob Benedict Seidelin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christoffer Soendergaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Peter Helding Kvist

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jacob Tveiten Bjerrum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

1 reference

1 May 2015

1 reference

Inflammatory Bowel Diseases

24 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1077-1088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Characterization of inflammatory bowel disease with urinary metabolic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Serum calprotectin as a biomarker for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Orthogonal projections to latent structures (O-PLS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Role of alpha-1 antitrypsin in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Disease associations in alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

The multifaceted effects of granulocyte colony‐stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Macrophage migration and invasion is regulated by MMP10 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Stromelysin-2 is Upregulated During Normal Wound Repair and is Induced by Cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

Granulocyte Macrophage Colony-Stimulating Factor Auto-Antibodies and Disease Relapse in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000348

10.1097/MIB.0000000000000348

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803506%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference